vimarsana.com
Home
Live Updates
Lawrence Eichenfield, MD: Responding to FDA Decision Not to
Lawrence Eichenfield, MD: Responding to FDA Decision Not to
Lawrence Eichenfield, MD: Responding to FDA Decision Not to Approve Dupilumab for CSU
Dr. Eichenfield used this interview segment to respond to the FDA’s recent decision not to approve dupilumab for chronic spontaneous urticaria.
Related Keywords
San Diego ,
California ,
United States ,
Las Vegas ,
Lawrence Eichenfield ,
Uc San Diego School Of Medicine ,
Drug Administration ,
Complete Response Letter ,
Biologics License Application ,
Rady Children ,
Clinical Dermatology Conference ,
Csu ,
Chronic Spontaneous Urticaria ,
Dupilumab ,
Fda ,
Crl ,